<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0163945.ref010">
 <label>10</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>McHutchison</surname>
   <given-names>JG</given-names>
  </name>, 
  <name>
   <surname>Gordon</surname>
   <given-names>SC</given-names>
  </name>, 
  <name>
   <surname>Schiff</surname>
   <given-names>ER</given-names>
  </name>, 
  <name>
   <surname>Shiffman</surname>
   <given-names>ML</given-names>
  </name>, 
  <name>
   <surname>Lee</surname>
   <given-names>WM</given-names>
  </name>, 
  <name>
   <surname>Rustgi</surname>
   <given-names>VK</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group</article-title>. 
  <source>The New England journal of medicine</source>. 
  <year>1998</year>;
  <volume>339</volume>(
  <issue>21</issue>):
  <fpage>1485</fpage>â€“
  <lpage>92</lpage>. 
  <pub-id pub-id-type="doi">10.1056/NEJM199811193392101</pub-id> .
  <?supplied-pmid 9819446?>
  <pub-id pub-id-type="pmid">9819446</pub-id>
 </mixed-citation>
</ref>
